KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Net Income - Minority (2016 - 2023)

Historic Net Income - Minority for Biogen (BIIB) over the last 15 years, with Q3 2023 value amounting to $4.1 million.

  • Biogen's Net Income - Minority fell 5287.36% to $4.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $4.1 million, marking a year-over-year decrease of 5287.36%. This contributed to the annual value of $9.5 million for FY2022, which is 11496.06% up from last year.
  • As of Q3 2023, Biogen's Net Income - Minority stood at $4.1 million, which was down 5287.36% from $6.4 million recorded in Q2 2023.
  • Biogen's Net Income - Minority's 5-year high stood at $21.6 million during Q1 2022, with a 5-year trough of -$462.9 million in Q2 2021.
  • Its 5-year average for Net Income - Minority is -$42.8 million, with a median of $8.7 million in 2022.
  • Its Net Income - Minority has fluctuated over the past 5 years, first soared by 37560.98% in 2020, then crashed by 332714.29% in 2021.
  • Over the past 5 years, Biogen's Net Income - Minority (Quarter) stood at $4.1 million in 2019, then skyrocketed by 246.34% to $14.2 million in 2020, then plummeted by 547.18% to -$63.5 million in 2021, then surged by 114.96% to $9.5 million in 2022, then tumbled by 56.84% to $4.1 million in 2023.
  • Its last three reported values are $4.1 million in Q3 2023, $6.4 million for Q2 2023, and $9.6 million during Q1 2023.